Recipient

Booker Group Limited

First report 11 Aug 2025•Latest report 11 Aug 2025

Recipient record

Reports, concerns and published responses

Private and voluntary organisations · Private limited company. This page brings together reports naming this recipient and response statements clearly connected to concerns raised in those reports.

Reports: 1
Published responses: 100%
Concerns addressed: 1
Stated actions: 12

Reports over time

Reports naming this recipient by issue year.

Evidence profile

Report topics

Share of this recipient’s reports compared with all other recipients.

100%published responses found

12stated actions described

Topic comparisons are not available in the current evidence snapshot.

Concerns and recipient responses

Statements from Booker Group Limited linked to the concerns in each report. Select any concern, action or position to view the source wording.

11 Aug2025
Surrey
Concerns raised1
1. Failure to check customers’ authorisation or entitlement before supplying medicinal products
Responses linked to these concerns
Each statement is shown once, even when linked to more than one concern.
Actions described in response 9
1. Action
  Conduct periodic senior-management and Responsible Person reviews of Quality Management System objectives, corrective actions and process improvements.
  Stated completed
2. Action
  Block medicinal-product purchases at the till for non-qualified customers without allowing staff to override the block.
  Stated completed
3. Action
  Update and distribute the Branch Manual with medicine-control procedures, including the requirement for relevant colleagues to confirm they understand and will follow them.
  Stated completed
1. Action
  Provide annual online GDP training with a competency test and restrict medicine sales duties to colleagues achieving the required pass mark.
  Stated completed
2. Action
  Control access to medicinal products through locked storage, staff accompaniment and prominent notices restricting bulk sales to appropriately qualified trade customers.
  Stated completed
3. Action
  Require customers entering the restricted medicines area to sign a declaration confirming their registration to purchase medicines.
  Status unclear
4. Action
  Operate a medicine-specific customer qualification process requiring documentary verification, category checks, management sign-off and recorded entitlement before permitting purchases.
  Stated completed
5. Action
  Recheck customers’ entitlement to purchase medicines every two years, covering historical accounts and new registrations from January 2026.
  Stated planned
6. Action
  Operate branch medicine audits by Responsible Persons, documenting deviations through corrective and preventive action plans.
  Stated completed
Respondent positions 1
1. Position
  Existing QMS changes, including tighter qualification and a till block, are considered sufficient; no further action is required.
  Existing arrangements considered sufficient
AI-generated summary

Paul Pidgeon · Prevention of Future Deaths report

This summary was generated using AI from the published report. Please read the original report for the complete account.

Report summary

Paul Pidgeon was found deceased at home on 20 March 2022 after deliberately overdosing on paracetamol the previous day. His death was caused by paracetamol toxicity, with coronary artery disease and hepatic steatosis contributing. The Coroner was concerned that Booker in Wimbledon, and potentially Booker more widely, may have sold bulk quantities of medicinal products to customers not authorised or entitled to supply them to the public, creating a risk of future deaths.

Read the report on judiciary.uk
Source evidence
How this individual concern was interpreted
PFD Monitor created a concise, searchable interpretation from the report wording shown below. The report was sent to Booker Group Limited; that does not assign responsibility.
PFD Monitor interpretation
Failure to check customers’ authorisation or entitlement before supplying medicinal products
Wider context from the report
“The Guidelines for the Good Distribution Practice of Medicinal Products for Human Use (2013) state that wholesale suppliers must ensure that they supply medicinal products only to those who are themselves in possession of a wholesale distribution authorisation or who are authorised or entitled to supply medicinal products to the public. The Guidelines go on to set out measures by which wholesalers can comply with that duty, including by requesting and checking a customer’s status. Mr Pidgeon was a mechanic and his business account with Booker was in relation to his garage business. His business did not involve the onward supply of medication to the public. However, he was able to bulk purchase both paracetamol and ibuprofen from Booker in Wimbledon on two occasions. It does not appear that any checks were carried out to confirm his status prior to the sales. ████████ ████████████████████████████████████████ The Coroner is therefore concerned that Booker in Wimbledon, and therefore potentially Booker more widely, may be selling medicinal products to customers who are not authorised or entitled to supply them to the public. Given, the potential for this to result in significant amounts of medicines being sold in single transactions, the Coroner is concerned that this gives rise to the risk of future deaths. ”
Open source report
Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation
Conduct periodic senior-management and Responsible Person reviews of Quality Management System objectives, corrective actions and process improvements.

Verbatim wording from the response
“7.4. Lastly, we have in place a periodic management review of the QMS objectives by Senior Management, the RP and relevant Area Leads to monitor the effectiveness of the system and implementation of CAPA Plans or improvements such as improving robustness of the qualification process.”

Source location
Response from Brooker Group Limited
Page 6 · response
Published 31 October 2025
Open published response
Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation
Block medicinal-product purchases at the till for non-qualified customers without allowing staff to override the block.

Verbatim wording from the response
“b) A till block was introduced in September 2025 so that any customers trying to buy medicines when they are not validated to do so will automatically be blocked from making the purchase. There is no option for branch staff to overwrite the till block. This will prevent anyone who isn't categorised on the Booker system as a retailer, school nurse or care home will not be able to purchase medicines.”

Source location
Response from Brooker Group Limited
Page 2 · response
Published 31 October 2025
Open published response
Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation
Update and distribute the Branch Manual with medicine-control procedures, including the requirement for relevant colleagues to confirm they understand and will follow them.

Verbatim wording from the response
“3.1. Booker has a Branch Manual in place for Medicine Controls which is held in paper copy in each of its branches as well as being available to colleagues online via our colleague communication system. Version 17 of the Branch Manual was in place at the time of Mr Pidgeon's purchases in 2022, and the current version (version 20) was issued on 15 August 2025.”

Source location
Response from Brooker Group Limited
Page 3 · response
Published 31 October 2025
Open published response
Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation
Provide annual online GDP training with a competency test and restrict medicine sales duties to colleagues achieving the required pass mark.

Verbatim wording from the response
“6.1. All Booker colleagues who are employed at a branch stocking medicinal products must undergo medicines compliance training. This training is undertaken as part of colleagues’ mandatory inductions when they first join Booker, and in 2022, there was a requirement for it to be refreshed every three years.”

Source location
Response from Brooker Group Limited
Page 6 · response
Published 31 October 2025
Open published response
Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation
Control access to medicinal products through locked storage, staff accompaniment and prominent notices restricting bulk sales to appropriately qualified trade customers.

Verbatim wording from the response
“5.1. All Booker sites which sell restricted products such as medicines and tobacco have a lockable, designated room in which those products are stored and displayed for sale. At the Wimbledon branch, this room is sealed off from the main floor of the branch by a lockable roller shutter. The roller shutter should remain closed unless a customer with the adequate customer qualification to enable them to purchase restricted products requests for a trained member of staff to open it for them and accompany them in the room while they make their purchases. In this way, Booker prevents not only access by customers who are not allowed to purchase restricted products but removes them from sight to other customers as well.”

Source location
Response from Brooker Group Limited
Page 5 · response
Published 31 October 2025
Open published response
Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation
Require customers entering the restricted medicines area to sign a declaration confirming their registration to purchase medicines.

Verbatim wording from the response
“c) Any customers who are visiting the restricted medicines area of the branch are required to sign a medicine customer declaration form to confirm they are appropriately registered to purchase medicines before leaving the store.”

Source location
Response from Brooker Group Limited
Page 2 · response
Published 31 October 2025
Open published response
Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation
Operate a medicine-specific customer qualification process requiring documentary verification, category checks, management sign-off and recorded entitlement before permitting purchases.

Verbatim wording from the response
“4.4. In order to purchase medicines from a Booker branch, Booker's medicine customer qualification process requires customers to be qualified and verified specifically for the purchasing of medicines prior to being able to do this/ or to continue to do this. This is over and above the process customers need to undergo to obtain a trade card. Booker's current system for customers qualifying to purchase medicines in its branches has been in place since April 2025.”

Source location
Response from Brooker Group Limited
Page 4 · response
Published 31 October 2025
Open published response
Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation
Recheck customers’ entitlement to purchase medicines every two years, covering historical accounts and new registrations from January 2026.

Verbatim wording from the response
“d) Booker's branch manual has been updated with the requirement for branch staff to recheck the validity of customers registered to buy medicines every 2 years, starting from January 2026. This process would include any historical accounts as well as any new registrations going forward.”

Source location
Response from Brooker Group Limited
Page 2 · response
Published 31 October 2025
Open published response
Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation
Operate branch medicine audits by Responsible Persons, documenting deviations through corrective and preventive action plans.

Verbatim wording from the response
“7.1. A vital part of the QMS system is the ability for the Company to monitor and audit that its systems have been implemented and are working as expected.”

Source location
Response from Brooker Group Limited
Page 6 · response
Published 31 October 2025
Open published response
Source evidence

How this respondent position was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation
Existing QMS changes, including tighter qualification and a till block, are considered sufficient; no further action is required.

Verbatim wording from the response
“8.3. We trust the above satisfies you that Booker has in place an effective system that complies with the GDP to ensure customers who are not authorised or entitled to supply medicines to the public are not able to purchase them from any Booker branches. Given the changes that Booker has already implemented in this area to strengthen its QMS, we hope this demonstrates that no further action is required beyond those changes already detailed above. We regret that we did not have the opportunity to provide the above information during the course of the inquest.”

Source location
Response from Brooker Group Limited
Page 7 · response
Published 31 October 2025
Open published response

Information checked against published PFD reports and official responses · Data reviewed 7 Sep 2026 · About data quality and limitations

Data last updated 7 September 2026

Reports, concerns and published responses

Reports over time

Concerns raised1

Failure to check customers’ authorisation or entitlement before supplying medicinal products

Actions described in response An action is something this recipient says it has done, is doing, or plans to do in response to the concern raised.9

Respondent positions A position is what this recipient says about the concern when it does not describe a specific action.1

Actions described in response 9

Respondent positions 1